Pressure BioSciences, Inc. to Discuss Third Quarter 2013 Financial Results and Provide a Business Update
SOUTH EASTON, Mass., Nov. 6, 2013 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:
Date: Thursday, November 7, 2013
Time: 4:15 PM Eastern Standard Time (EST)
To attend this teleconference via telephone:
Dial-in: (800) 391-2548 (U.S.); (866) 627-1646 (Canada); (302) 709-8328 (International)
Conference ID: 861819
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call and will be accessible through the Company's website for 30 days.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.
For more information about PBI and this press release, please click on the following link:
Richard T. Schumacher, President & CEO
Pressure BioSciences, Inc.
Richard P. Thomley, Acting CFO
SOURCE Pressure BioSciences, Inc.